Arthritis and Rheumatism - McMaster Experts

publication venue for

All-Cause Mortality For Patients with Rheumatoid Arthritis In a Universal Public Health Care System 2013
Can People With Rheumatoid Arthritis Self Monitor Their Disease Activity? 2013
Can Satisfactory Reliability Of The 7-Joint Ultrasound Score Be Attained By Inexperienced Readers In a Single Calibration Exercise? Results From The Biodam Program 2013
Cardiac Involvement In Granulomatosis With Polyangiitis 2013
Clinical Value Of Commonly-Measured Laboratory Tests In Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) 2013
Correlation Of Individual Health Assessment Questionnaire (HAQ) Questions With Outcome Measures In Rheumatoid Arthritis: Implications For Instrument Reduction. 2013
Corticosteroid Use In Rheumatoid Arthritis Patients On Infliximab: Treatment Implications Based On A REAL-WORLD Canadian Population 2013
Cytokines, Oxidative Stress Markers and Brain-Derived Neurotrophic Factor In Fibromyalgia Syndrome 2013
Development and Usability Testing Of The Arthritis Health Journal: An Online Tool To Promote Self-Monitoring In People With Rheumatoid Arthritis. 2013
Does Specific Joint Involvement In Rheumatoid Arthritis Patients Predict Patient Reported Outcomes? Implications For Clinical Practice 2013
Effectiveness Of Etanercept In Elderly Patients With Rheumatoid Arthritis: A Single Center Retrospective Study 2013
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss Syndrome): Comparison Of The Independent French Vasculitis Study Group and Italian-Pisa Patient Cohorts and Cross-Validation Of Cluster Analysis 2013
Further Reduction In Nonvertebral Fracture Rate Is Observed Following 3 Years Of Denosumab Treatment: Results With Up To 7 Years In The Freedom Extension 2013
Incidence and Trend Of Osteoarthritis In An Administrative Database From British Columbia, Canada 2013
Multicenter Validation Of The Lupus Activity Scoring Tool (LAST) As Compared To The Selena Sledai (SS) Modification 2013
Osteoporosis Medication Adherence: Reasons For Stopping and Not Starting 2013
Persistence At 12 Months With Denosumab (Prolia (R)) In Postmenopausal Women With Osteoporosis: Interim Results From a Prospective Observational Study 2013
Serum S100A8/S100A9 and S100A12 As a Marker Of Disease Activity In Giant Cell Arteritis 2013
Team Managed Care From a Patient's Perspective: A Study Of Biological Patients At a Canadian Centre 2013
The Birmingham Vasculitis Activity Score As a Measure Of Disease Activity In Patients With Giant Cell Arteritis 2013
The Spectrum of childhood Inflammatory Brain Diseases; An Increasingly Recognised Field 2013
Variability In Patient Characteristics and Outcomes In Rheumatoid Arthritis Upon Infliximab Treatment Based On The Size Of Biologic Treatment Registry Site 2013
Variability in the Classification of Remission Among Disease Activity Indices and Their Correlation: An Analysis From a Prospective, Observational Registry 2013
Vertebral Fractures In The 3 Year Period Following Steroid Initiation Among Children With Chronic Illnesses 2013
Accuracy of Canadian Health Administrative Databases in Identifying Patients with Rheumatoid Arthritis Seen by Rheumatologists 2012
Accuracy of Canadian Health Administrative Databases in Identifying Patients with Rheumatoid Arthritis Using a Random Sample of 7500 Patients Seen in Primary Care. 2012
Burden of Childhood Central Nervous System Vasculitis: Identifying High Risk Factors for Poor Cognitive Outcome. 2012
Care Gap in the Treatment of Patients with High Risk for Fractures in a Single Canadian Academic Center 2012
Evaluation of a New Educational Tool: A Resident's Guide to Pediatric Rheumatology. 2012
Identification of Disease-Specific Neuroimaging Phenotypes in Childhood Inflammatory Brain Diseases. 2012
Low Fracture Incidence Is Maintained in Postmenopausal Women >= 75 Years with Osteoporosis with Long-Term Denosumab Treatment. 2012
Methotrexate and Interstitial Lung Disease in Rheumatoid Arthritis - A Systematic Literature Review and Meta-Analysis 2012
New Disease Manifestations After Diagnosis in Six Types of Vasculitis. 2012
Osteoporosis and Vertebral Fractures Are Important Determinants of Cardiovascular Disease in Rheumatoid Arthritis. 2012
Potential Barriers That Limit Access to Rheumatologists Among Patients with Early Rheumatoid Arthritis in a Universal Access Health Care System 2012
Relative, Reliability-Adjusted Diagnostic Test Accuracy of Erosion Detection Between Magnetic Resonance Imaging and Radiography in Rheumatoid Arthritis 2012
Reliability of the Early Erosions in Rheumatoid Arthritis Software When Quantifying Bone Loss. 2012
Systematic Review of the Association Between Magnetic Resonance Imaging and Radiographic Detection of Erosions in Rheumatoid Arthritis 2012
The Effect of Evaluation Variability At the Unit of Measurement On the Reliability of Omeract Ramris and Van Der Heijde-Modified Sharp Score. 2012
Trying to Improve Care: A Review of the Morbidity and Mortality Conference in the Division of Rheumotology 2012
Urinary Biomarkers in Vasculitis Associated with Anti-Neutrophil Cytoplasmic Antibodies. 2012
Validation of BASDAI and BASFI in Children with Spondyloarthritis 2012
Vascular Calcification On Hand and Feet X-Rays, VFA Imaging of the Spine, and Cardiovascular Disease in Rheumatoid Arthritis. 2012
Vertebral Fracture Assessment-Detected Abdominal Aortic Calcification Enhances Cardiovascular Disease Risk Stratification of Rheumatoid Arthritis Patients. 2012
Are Patients with ANCA-Associated Vasculitis Entered In Clinical Trials Representative of Patients Followed In Observational Cohorts? 2011
Comparison of CNS Vasculitis in Children and Adults: Is This the Same Disease Entity? 2011
Distinct Phenotypical Clusters In Childhood Inflammatory Brain Diseases: Implications for Diagnostic Evaluation 2011
Distribution of Large Artery Lesions in Takayasu's Arteritis Compared to Giant Cell Arteritis 2011
Incident Vertebral Fractures (VF) 12 Months After Glucocorticoid (GC) Initiation in Children with Rheumatic Disorders (RD) 2011
Insulin Resistance and Its Association with Phospholipid Profile, Carotid Intimal-Medial Thickness and Carotid Plaque Area in Women with Systemic Lupus Erythematosus 2011
Is Dietary Intake of Patients with Systemic Lupus Erythematosus Adequate? 2011
Optimal Definition for the Duration of Sustained Remission in ANCA-Associated Vasculitis 2011
Relapses Among Patients with Giant Cell Arteritis. 2011
The Gait, Arms, Legs & Spine Exam: An Effective Screening Tool for Rheumatoid Arthritis When Used by Family Physicians and Nurse Practitioners. 2011
The Role of Fatty Acid Composition in Antiphospholipid Syndrome and Systemic Lupus Erythematosus 2011
Vitamin D in Obesity (VIDeO): Assessing Vitamin D Deficiency in the Bariatric Population 2011
Decreasing Hospital Stay in Wegener's Granulomatosis - Analysis of a Tertiary Center Inpatient Experience. 2008
Absolute death rates by fracture type in Canadians 2008
Assessment of reproductive history in systemic sclerosis 2008
Impact of a video on learning the GALS musculoskeletal screening exam in medical students 2008
Malnutirition is common in systemic sclerosis: Results from the Canadian scleroderma research group database 2008
Relationship between compartmental and mid-subchondral tibial bone texture in knees with severe osteoarthritis 2008
Serious infections in a population-based cohort of older individuals with rheumatoid arthritis 2008
The GALS screening tool: A quick and easy screen for MSK conditions in the primary care setting 2008
The impact of rib fractures on health related quality of life is underestimated 2008
Tnf-alpha-308(a) variant predicts poor response to tnfa inhibitors in rheumatoid arthritis patients: A meta-analysis 2008
A prospective lipid profile evaluation in early rheumatoid arthritis and its relation to disease activity. 2006
Costs of fragility fractures among men are considerable in managed care. 2006
Determining the construct validity and responsiveness of the e-Ouch electronic pain diary for adolescents with arthritis. 2006
Family physicians' utilization of calcium and vitamin D in patients with fractures following an educational intervention: Canadian quality circle (CQC) national project. 2006
Lack of isoniazid hepatotoxicity in inflammatory arthritis patients with latent tuberculosis treated with DMARDs and tumor necrosis factor inhibitors therapy. 2006
Lupus nephritis treatment: Different preferences between low-literacy patients and physicians. 2006
Medial tibial and femoral cartilage volume and thickness measurements correlate with pain and function in individuals with knee OA. 2006
Minimum joint space width values in healthy individuals and patients with knee OA. 2006
Postpartum management of women at increased risk of thrombosis results of a Canadian pilot survey. 2006
Results from the HepASA trial: Low molecular weight heparin plus ASA vs ASA only for recurrent pregnancy loss. 2006
Risedronate treatment produces a significant reduction in the risk of clinical vertebral fractures over 3 years. 2006
Self-reported arthritis after a large community water outbreak of E coli and campylobacter follows a dose response for diarrhea severity. 2006
Symptoms correlate with radiographic measures of disease severity in those with knee osteoarthritis. 2006
The new indexes SDAI and CDAI in early arthritis: Similar performance to DAS 28 index. 2006
Reliability of exercise testing parameters in children with juvenile arthritis. 2005
Reliability of functional activity questionnaires in children with juvenile arthritis. 2005
Elevated serum total cholesterol is associated with poor renal outcome in systemic lupus erythematosus (SLE). 2005
Epigenetic regulation of TNF alpha. 2005
Family physicians' awareness of fracture, the appropriate utilization of bone mineral density testing, and the rate that bisphosphonates are prescribed to their patients with fracture: Canadian Quality Circle (CQC) Pilot Project. 2005
Predictors of individual lipid abnormalities in children with pediatric SLE. 2005
Risedronate demonstrates efficacy over a wide range of risk for osteoporotic fracture. 2005
The use of anticoagulants in the management of recurrent thrombosis in systemic lupus erythematosus: A decision analysis 2004
Thrombosis occurs early after diagnosis of systemic lupus erythematosus (SLE). 2004
Measurements of health-related quality of life using the health utilities index 3 in Canadian women: The impact of self-reported osteoporosis in the Canadian multicentre osteoporosis study (CaMos) 2004
Prevalence of undiagnosed osteoporosis in Canadians age 65 years and older: the Canadian Multicentre Osteoporosis Study (CaMos). 2004
Screening results for 847 women attending a recurrent pregnancy loss clinic. 2004
Serial knee radiographic changes can be followed using 2 medial minimum joint space width. 2004
The contingent valuation method-validation in patients with rheumatoid arthritis. 2004
The usefulness of seven easily measureable risk factors for early recognition of future osteoporotic fracture 2004
What is the probability a new vertebral fracture is present? Data from the MORE and fracture prevention trials 2004
Adenoviral gene transfer of interleukin-1 or TNF induces synovial inflammation in wild type and oncostatin M receptor beta deficient mice. 2003
Characteristics that predict new fragility non-vertebral fracture in postmenopausal women who are enrolled in the Canadian Multicentre osteoporosis study (CaMos). 2003
Effectiveness and safety of hylan G-F 20 compared to steroid injections in patients with knee osteoarthritis. 2003
Evaluation of the OARSI and OMERACT-OARSI set of responder criteria in patients treated with Hylan G-F 20 for knee osteoarthritis. 2003
Fracture risk reduction due to antiresorptive treatment is independent of the magnitude of BMD improvement. 2003
Men have a higher rate of prevalent fractures compared to women when started on bisphosphonate therapy: The Canadian Database of Osteoporosis and Osteopenia. 2003
Participant characteristics of postmenopausal women that predict new clinically recognized vertebral fracture in a three-year observational study: The Canadian Multicentre osteoporosis study (CaMos) 2003
Predictors of change of disease modifying antirheumatic drugs in patients with rheumatoid arthritis from the CORRONA database. 2003
Predictors of early failure of bisphosphonate therapy: The Canadian database of osteoporosis and osteopenia (CANDOO). 2003
Risk factors associated with quality of life (QOL) in postmenopausal women with prevalent vertebral fractures: the Canadian database of osteoporosis and osteopenia (CANDOO). 2003
The human cost of fractures in community dwelling older adults. 2003
The relations between medial tibiofemoral minimum joint space width in the knee and bone mineral density in the spine, hip, distal femur and proximal tibia in healthy individuals. 2003
A systematic review of statistical policies guiding interim analysis in clinical trials. 2002
Do therapeutic exercise and sleeping neck support benefit patients with chronic neck pain? 2002
Impact of drug plan coverage on NSAID and coxib prescribing by primary care physicians. 2002
Impact of etanercept (Enbrel (R)) on employment and functional status in a community setting (the Enbrel (R) community health outcomes [ECHO) study). 2002
Laser therapy for mechanical neck disorders: A Cochrane review. 2002
Thermal agents for mechanical neck disorders: A Cochrane review. 2002
CANDOO: A longitudinal Canadian multi-center tertiary-care network for observational research in osteoporosis and osteopenia using standardized clinical practice data: 11 years of follow-up. 2001
Characteristics of patients with OA receiving NSAID prescriptions from their primary care physicians - Results from the CANOAR study. 2001
Measures of appropriateness of use of NSAIDs and coxibs in patients with OA by primary care physicians - Results from the CANOAR study. 2001
The impact of osteoporotic fractures on Health Related Quality of Life (HRQL) as measured by the health utilities index. 2001
The impact of treatment interventions on health related qualtiy of life (HRQL) in post-menopausal women registered in the Canadian database of osteoporosis and osteopenia (CANDOO) patients. 2001
A randomized multi-site controlled trial of group psychotherapy(GPT) for SLE. 2000
Effectiveness of etidronate and alendronate in the treatment of osteoporosis in males: A prospective observational study. 2000
Follow-up of randomized controlled trial of exercise, education and a combination of exercise and education in women with fibromyalgia. 2000
Medicinal and injection therapies for neck pain: A systematic review. 2000
Non-vertebral fractures and quality of life. 2000
Patient adherence to bisphosphonate therapy. 2000
Predicting changes in self-efficacy after intervention programs for persons with fibromyalgia. 2000
Tolerability of risedronate in alendronate-intolerant postmenopausal women. 2000
Vertebral fractures and quality of life. 2000
A randomized controlled trial of exercise, education and the combination of exercise and education in persons with fibromyglia. 1999
A single administration of the IL-4 or IL-12 gene along with self-peptides has long-lasting but opposite effects on autoantibody production in lupus mice. 1999
A single administration of vectors that express IL-4 or IL-12 genes, with self-peptides induce long-lasting, but opposite, effect on anti-DNA antibody production in lupus mice. 1999
Fear avoidance in persons with fibromyalgia classified according to the multidimensional pain inventory. 1999
Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. 1999
The relationship between physical fitness and outcome measures in persons with fibromyalgia. 1999
Addition of bisphosphonate therapy with etidronate or alendronate to stable estrogen replacement therapy in postmenopausal women increases lumbar spine and femoral trochanter bone mineral density. 1998
Adenovector-mediated gene transfer of active transforming growth factor-beta(1) in the murine knee joint induces fibrosis and osteophyte formation. 1998
Characteristics of persons with fibromyalgia classified according to the multidimensional pain inventory. 1998
Cochrane review of alendronate for prevention and treatment of postmenopausal osteoporosis 1998
Cochrane review on fluoride therapy to prevent postmenopausal osteoporosis 1998
Etidronate in the prevention of corticosteroid-induced osteoporosis: One year of follow-up on calcium only. 1998
How "soft" are soft neurological signs? The relationship of subjective neuropsychiatric complaints to cognitive function in SLE. 1998
Improved gastrointestinal tolerance and patient preference of Azulfidine (sulfasalazine) EN-TABS (R) versus uncoated tablets in rheumatoid arthritis. 1998
Intermittent cyclical therapy with etidronate prevents corticosteroid-induced bone loss: Three years of follow-up. 1998
Intra-articular interleukin-10 gene transfer with an adenoviral vector suppresses collagen-induced arthritis 1998
Micellar taxol: Involution of collagen-induced arthritis is associated with cartilage protection and angiogenesis regression. 1998
Mouse oncostatin m regulates tissue inhibitor of metalloproteinase-1 and interleukin-6 expression by mouse synovial fibroblasts in vitro. 1998
Overexpression of mouse oncostatin M in joints by adenovirus vector causes pannus-like alterations in synovium of mice. 1998
Prevention of corticosteroid-induced osteoporosis with etidronate: Pooled results from two clinical trials. 1998
Protection against cartilage damage and bone-erosion in collagen-induced arthritis by local adenoviral vector-mediated interleukin-4 expression in the mouse knee joint. 1998
Reliability of radiographic scoring of degenerative changes in the lumbar spine (DCLS). 1998
Six minute walk test for fibromyalgia - Measure of fitness or function? 1998
The effect of etidronate on lumbar spine bone mineral density in men. 1998
Bone density results in women treated with low molecular weight heparin (LMWH) in pregnancy 1997
Clinical profile of cases in a worksite study of low back pain according to WCB claim and lost-time status at baseline and 26 weeks. 1997
Cytokine gene transfer modifies inflammation and regulates cytokine and chemokine production in murine arthritis. 1997
Development of the Australian/Canadian (AUSCAN) osteoarthritis (OA) hand index. 1997
Intermittent cyclical therapy with etidronate in the prevention of corticosteroid-induced osteoporosis. 1997
Low molecular weight heparin (LMWH) and ASA therapy in women with autoantibodies and unexplained recurrent fetal loss (U-RFL). 1997
Results of a prospective long-term study of the effects of early institution of 2nd-line agents in rheumatoid arthritis. 1997
A randomized controlled trial (RCT) to evaluate the efficacy of community-based physical therapy (PT) in the treatment of people with rheumatoid arthritis (RA). 1996
A randomized, double-blind, placebo-controlled trial of the effects of fluoride on lumbar spine bone mineral density in patients with rheumatoid arthritis. 1996
Effects of education on decisions to start preventative hormone therapy by postmenopausal women with fractures. 1996
Follow-up of interdisciplinary medical and behavioural treatment for fibromyalgia. 1996
How common is vitamin D deficiency in Canadian women living in the community? 1996
Magnetic resonance imaging for the detection of early sacroiliitis. 1996
Micellar taxol and methotrexate in collagen-induced arthritis: Suppression of synovial angiogenesis and regression of arthritis. 1996
Osteoarthritis of the knee: Viscosupplementation with hylan G-F20 in clinical practice. 1996
Transient IL-10 and IL-12 overexpression modifies disease in murine collagen induced arthritis. 1996
What is the yield of screening for secondary causes of osteoporosis? 1996
A RANDOMIZED CONTROLLED TRIAL TO EVALUATE THE EFFECTIVENESS OF A RHEUMATOLOGY DAY HOSPITAL PROGRAM 1995
INTERMITTENT CYCLIC THERAPY WITH ETIDRONATE PREVENTS CORTICOSTEROID-INDUCED BONES LOSS - 2 YEARS OF FOLLOW-UP 1995
THE ASSOCIATION BETWEEN ABDOMINAL MUSCLE STRENGTH AND INCIDENCE OF LOW-BACK-PAIN - A RANDOMIZED CONTROLLED TRIAL 1995
THE CHARACTERIZATION AND MEASUREMENT OF EARLY-MORNING STIFFNESS IN PEOPLE WITH RHEUMATOID-ARTHRITIS 1995
INTERMITTENT CYCLIC THERAPY WITH ETIDRONATE PREVENTS CORTICOSTEROID-INDUCED BONE LOSS - 2 YEARS OF FOLLOW-UP 1995
CD48(BLAST-1) ALLELES IN BLACK POPULATIONS - ALLELIC DISTRIBUTION DEVIATES FROM HARDY-WEINBERG EQUILIBRIUM IN NORMALS AND THE S-ALLELE IS INCREASED IN SLE 1993
COGNITIVE CORRELATES OF ANTIPHOSPHOLIPID ANTIBODY POSITIVITY IN SLE 1993
FISH-OIL N-3 FATTY-ACIDS ALTER DIACYLGLYCEROL (DAG) FORMATION IN INFLAMMATORY MACROPHAGES - A POTENTIAL EICOSANOID-INDEPENDENT MECHANISM OF THEIR ACTION 1993
INTERMITTENT CYCLIC ETIDRONATE THERAPY (ICT) PREVENTS CORTICOSTEROID-INDUCED BONE LOSS 1993
LYMPHOCYTE ANTIBODY SPECIFICITIES AND NEUROPSYCHIATRIC LUPUS 1993
PULSE GLUCOCORTICOSTEROID (GCS) THERAPY IN RA PATIENTS INHIBITS WHOLE-BLOOD LEUKOTRIENE B4(LTB4) BIOSYNTHESIS EX-VIVO 1993
VITAMIN-D AND CALCIUM IN THE PREVENTION OF CORTICOSTEROID-INDUCED OSTEOPOROSIS - FOLLOW-UP OVER 3 YEARS 1993
VITAMIN-D DEFICIENCY IS COMMON IN ELDERLY OSTEOPOROTIC PATIENTS 1993
FISH OIL N-3 FATTY-ACIDS ALTER DIACYLGLYCEROL (DAG) FORMATION IN INFLAMMATORY MACROPHAGES - A POTENTIAL EICOSANOID-INDEPENDENT MECHANISM OF THEIR ACTION 1993
PULSE GLUCOCORTICOSTEROID (GCS) THERAPY IN RA PATIENTS INHIBITS WHOLE-BLOOD LEUKOTRIENE-B4 (LTB4) BIOSYNTHESIS EXVIVO 1993
SCREENING-TESTS HAVE A HIGH-YIELD IN ELDERLY OSTEOPOROTIC PATIENTS 1993
BEHAVIORAL DYSFUNCTION CORRELATES WITH THE ONSET OF AUTOIMMUNITY IN MRL-LPR MICE 1992
COGNITIVE DEFICIT IN NONNEUROPSYCHIATRIC SLE (FACT OR FICTION) 1992
COMPARABILITY OF VISUAL ANALOG AND VERBAL RATING-SCALES IN MEASURING THE PAIN OF RHEUMATOID-ARTHRITIS 1992
MCRHEUM - UTILITY MEASUREMENT IN PEOPLE WITH EARLY RHEUMATOID-ARTHRITIS 1992
NASAL SALMON-CALCITONIN IN THE PREVENTION OF CORTICOSTEROID-INDUCED OSTEOPOROSIS 1992
RATING RHEUMATOLOGY JOURNALS 1992
THE DOMINANT IGG HUMAN ANTI-HSP60 AUTOANTIBODIES BIND TO GROEL BUT NOT TO HSP65 1992
THE FACIAL ANIMATION SCALE - A VALID AND RELIABLE NEW METHOD OF PAIN MEASUREMENT IN PATIENTS WITH RHEUMATOID-ARTHRITIS 1992
Progressing Toward, and Recovering From, Knee Replacement Surgery: A Five‐Year Cohort Study. 65:3304-3313. 2013
Association of Granulomatosis With Polyangiitis (Wegener's) With HLA–DPB1*04 and SEMA6A Gene Variants: Evidence From Genome‐Wide Analysis. 65:2457-2468. 2013
Reply. 64:3821-3822. 2012
Reply. 64:3058-3058. 2012
Childhood primary angiitis of the central nervous system: Identifying disease trajectories and early risk factors for persistently higher disease activity. 64:1665-1672. 2012
Developing a provisional definition of flare in patients with established gout. 64:1508-1517. 2012
The excess burden of osteoarthritis in the province of Ontario, Canada. 64:1153-1161. 2012
Anti–N‐methyl‐D‐aspartate receptor encephalitis: A newly recognized inflammatory brain disease in children. 63:2516-2522. 2011
Alteration of sensory neurons and spinal response to an experimental osteoarthritis pain model. 62:2995-3005. 2010
The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus. 62:863-868. 2010
Prevalence and clinical correlates of pruritus in patients with systemic sclerosis. 61:1765-1770. 2009
A novel experimental approach in treating central nervous system lupus: Kudos and Kicks. 60:3531-3533. 2009
Health‐related quality of life in systemic sclerosis: A systematic review. 61:1112-1120. 2009
Naturopathic treatment of rotator cuff tendinitis among Canadian postal workers: A randomized controlled trial. 61:1037-1045. 2009
Being careful: A grounded theory of emergent chronic knee problems. 61:937-943. 2009
Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis: Evidence from a sample of 659 Canadian Scleroderma Research Group Registry patients. 61:966-973. 2009
Anaerobic‐to‐aerobic power ratio in children with juvenile idiopathic arthritis. 61:787-793. 2009
Time course and nature of brain atrophy in the MRL mouse model of central nervous system lupus. 60:1764-1774. 2009
Measuring shoulder function: A systematic review of four questionnaires. 61:623-632. 2009
Medial opening wedge high tibial osteotomy: A prospective cohort study of gait, radiographic, and patient‐reported outcomes. 61:648-657. 2009
Development and testing of a decision board to help clinicians present treatment options to lupus nephritis patients in Brazil. 61:37-45. 2009
The cost of systemic sclerosis. 61:119-123. 2009
Assessment of reproductive history in systemic sclerosis. 59:1661-1664. 2008
The need for standardization: A literature review of indirect costs of rheumatoid arthritis and osteoarthritis. 59:1027-1033. 2008
Findings of extensive variation in the types of outcome measures used in hip and knee replacement clinical trials: A systematic review. 59:876-883. 2008
Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis. 59:504-509. 2008
High rates of depressive symptoms among patients with systemic sclerosis are not explained by differential reporting of somatic symptoms. 59:431-437. 2008
Reliability and validity of the center for epidemiologic studies depression scale in patients with systemic sclerosis. 59:438-443. 2008
Clinical correlates of quality of life in systemic sclerosis measured with the World Health Organization Disability Assessment Schedule II. 59:279-284. 2008
Quality of life in systemic sclerosis: Psychometric properties of the World Health Organization Disability Assessment Schedule II. 59:270-278. 2008
Reliability of exercise testing and functional activity questionnaires in children with juvenile arthritis. 57:1446-1452. 2007
The effects of vigorous exercise training on physical function in children with arthritis: A randomized, controlled, SINGLE‐BLINDED trial. 57:1202-1210. 2007
Global analyses of gene expression in early experimental osteoarthritis. 56:1854-1868. 2007
Longitudinal examination of lipid profiles in pediatric systemic lupus erythematosus. 56:631-638. 2007
Natural killer T cells in families of patients with systemic lupus erythematosus: Their possible role in regulation of IGG production. 56:303-310. 2007
Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: Implications for cartilage degradation in arthritis. 54:3244-3253. 2006
Acute occlusive large vessel disease leading to fatal stroke in a patient with systemic lupus erythematosus: Arteritis or atherosclerosis?. 54:908-913. 2006
Determinants of self efficacy for physical tasks in people with knee osteoarthritis. 55:94-101. 2006
Interleukin‐1 in combination with oncostatin M up‐regulates multiple genes in chondrocytes: Implications for cartilage destruction and repair. 54:540-550. 2006
Incidence rates of arterial and venous thrombosis after diagnosis of systemic lupus erythematosus. 53:609-612. 2005
Effect of cardiovascular comorbidities and concomitant aspirin use on selection of cyclooxygenase inhibitor among rheumatologists. 53:12-17. 2005
Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis. 51:177-183. 2004
Oncostatin M in combination with tumor necrosis factor α induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo. 48:3404-3418. 2003
The relationship between self‐report and performance‐related measures: Questioning the content validity of timed tests. 49:535-540. 2003
Growth plate damage, a feature of juvenile idiopathic arthritis, can be induced by adenoviral gene transfer of oncostatin M: A comparative study in gene‐deficient mice. 48:1750-1761. 2003
Hematopoietic stem cell transplantation for severe and refractory lupus. 46:2917-2923. 2002
Frequency of infection in patients with rheumatoid arthritis compared with controls: A population‐based study. 46:2287-2293. 2002
Predictors of infection in rheumatoid arthritis. 46:2294-2300. 2002
Local interleukin‐12 gene transfer promotes conversion of an acute arthritis to a chronic destructive arthritis. 46:1379-1389. 2002
Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty‐year period. 46:625-631. 2002
Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo-controlled extension trial. 44:202-211. 2001
Quality of life in systemic lupus erythematosus patients during more and less active disease states: Differential contributors to mental and physical health. 12:401-410. 1999
Isometric strength measurements in children with arthritis: Reliability and relation to function. 12:238-246. 1999
The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. 42:599-608. 1999
Oncostatin M stimulates monocyte chemoattractant protein‐1‐ and interleukin‐1‐induced matrix metalloproteinase‐1 production by human synovial fibroblasts in vitro. 40:2139-2146. 1997
The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus.. 40:809-813. 1997
The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index in patients with Systemic Lupus Erythematosus. 40:809-813. 1997
The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosus. 39:363-369. 1996
Review cognitive deficit associated with rheumatic diseases: neuropsychological perspectives. 38:1363-1374. 1995
American college of rheumatology preliminary definition of improvement in rheumatoid arthritis. 38:727-735. 1995
Reduced joint counts in rheumatoid arthritis clinical trials. 37:463-464. 1994
Acupuncture for the treatment of pain of osteoarthritic knees. 7:118-122. 1994
Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus. 37:1311-1320. 1994
Lymphocyte Antigens in Neuropsychiatric Systemic Lupus Erythematosus. 37:369-375. 1994
Takayasu arteritis with acute interstitial pneumonia and coronary vasculitis: expanding the spectrum. report of a case. 36:1175-1178. 1993
Quality of life issues in women with vertebral fractures due to osteoporosis. 36:750-756. 1993
The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials.. 36:729-740. 1993
The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. 36:729-740. 1993
Mycobacteria and human heat shock protein—specific cytotoxic t lymphocytes in rheumatoid synovial inflammation. 35:270-281. 1992
Activation of Synovial Fluid T Lymphocytes by 60‐Kd Heat‐Shock Proteins in Patients with Inflammatory synovitis. 35:43-48. 1992
Letters. 34:1342-1344. 1991
Signal measurement strategies: are they feasible and do they offer any advantage in outcome measurement in osteoarthritis?. 33:739-745. 1990
Cost‐effectiveness of inpatient and intensive outpatient treatment of rheumatoid arthritis. A randomized, controlled trial. 32:1505-1514. 1989
A critical review of compliance studies in rheumatoid arthritis. 27:1227-1233. 1984
Anemia associated with rheumatoid disease. 26:28-34. 1983

Arthritis and Rheumatism Journal

Overview

publication venue for

has subject area

Identity

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)